Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes

Leukemia

Volumn 11, Issue 6, 1997, Pages 839-845

  Bouscary, D ^a,b   De Vos, J ^a   Guesnu, M ^a   Jondeau, K ^a   Viguier, F ^c   Melle, J ^b   Picard, F ^a,b   Dreyfus, F ^a,b   Fontenay Roupie, M ^a,b  

^a Laboratoire d'Hématologie   (France)

^b Université Paris Descartes   (France)

^c HÔTEL DIEU   (France)

Author keywords

Apoptosis; Fas; Myelodysplasia

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CD34 ANTIGEN; FAS ANTIGEN; GLYCOPHORIN; MONOCLONAL ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; BURST FORMING UNIT E; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMING UNIT GM; CONTROLLED STUDY; CYTOPENIA; DNA SYNTHESIS INHIBITION; ERYTHROID CELL; ETIOLOGY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; STEM CELL;

EID: 0030926080     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400654     Document Type: Article

References (24)

1. Beris P. Primary clonal myelodysplastic syndromes. Semin Hematol 1989; 26: 216-233.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. The French-American-British cooperative group: proposals for the classification of myelodysplastic syndromes. Br J Haematol 1982; 51: 189-199.
3. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shelly V, Parcharidou A, Loew J, Marcus B, Khan Z, Chaney C, Showel J, Gregory S, Preisler H. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood 1995; 86: 268-276.
4. Hatake K, Tomizuka H, Ikeda M, Tsunoda JI, Hoshino Y, Ostsuki T, Tasahara T, Yonehara S, Miura Y. The presence of apoptosis in refractory anemia of myelodysplasia. In: Abraham NG (ed). Molecular Biology of Haematopoiesis. Intercept: Andover, MD, 1994, p 127.
5. Bogdanovic AD, Jankovic GM, Colovic MD, Trpinac DP, Bumbasirevic VZ. Apoptosis in bone marrow of myelodysplastic syndrome patients. Blood 1996; 87: 3064 (letter).
6. Sameshima M, Hase A, Seto Y, Nagata S. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1995; 66: 233-247.
7. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC, Ponstigl H, Krammer PH. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor family. J Biol Chem 1992; 267: 10709-10715.
8. Parijs LV, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Current Opin Immunol 1996; 8: 355-361.
9. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Tanigushi N. Differential expression of Bcl-2 and susceptibility to anti-Fas mediated cell death in peripheral blood lymphocytes, monocytes and neutrophils. Blood 1994; 84: 1201-1208.
10. Matsumoto K, Schleimer RP, Saito H, Likura Y, Bochner BS. Induction of apoptosis in human eosinophils by anti-Fas antibody treatment in vitro. Blood 1995; 86: 1437-1443.
11. Nagafuji K, Shibuya T, Harada M, Mizuno SI, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 1995; 86: 883-889.
12. + human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood 1995; 85: 3086-3190.
13. Stahnke K, Kleihauer E, Debatin KM. Expression of Apo-1 (Fas/CD95) on human hematopoietic cells and sensitivity towards Apo-1 induced cell death. Blood 1995; 86: 581 (Abstr.).
14. Rösi F. A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res 1992; 19: 5243-5244.
15. + cells of patients with aplastic anemia. Br J Haematol 1995; 91: 245-252.
16. Komada Y, Zhou YW, Zhang XL, Xue HL, Sakai H, Tanaka S, Sakatoku H, Sakurai M. Fas receptor (CD95)-mediated apoptosis is induced in leukemic cells entering G1B compartment of the cell cycle. Blood 1995; 86: 3848-3860.
17. Lepelley P, Campergue L, Grardel N, Preudhomme C, Cosson A, Fenaux P. Is apoptosis a massive process in myelodysplastic syndromes? Br J Haematol 1996; 95: 368-371.
18. Gersuk GM, Lee JW, Beckham CA, Anderson J, Deeg HJ. Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndromes. Blood 1996; 88. 1122-1123.
19. Shetty V, Sanoy A, Payne G, Mundle S, Marcus B, Loew J, Wright V, Adler S, Gregory S, Raza A. High degree of TNF-alpha may be responsible for extensive apoptosis of bone marrow cells in MDS. Cell Prolif 1994; 27: 411 (Abstr.).
20. Min YH, Lee S, Lee JW, Chong SY, Hahn JS, Ko YW. Expression of Fas antigen in acute myeloid leukemia is associated with therapeutic response to chemotherapy. Br J Haematol 1996; 93. 928-930.
21. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL-2 family and cell death. Blood 1996; 88: 386-401.
22. Jonveaux P. Mutations of the P53 gene in myelodysplastic syndromes. Oncogene 1991; 6: 2243-2247.
23. Lepelley P, Soenen V, Preudhomme C, Merlat A, Cosson A, Fenaux P. Bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis. Leukemia 1995; 9: 726-730.
24. Jensen IM, Hockland P. The proliferative activity of myelopoiesis in myelodysplasia by multiparameter flow cytometry. Br J Haematol 1994; 87: 477-482.